Merck · 9 hours ago
Specialist, Logistics
Merck is dedicated to advancing the prevention and treatment of diseases in people and animals through innovative health solutions. The Logistics Support Analyst role is crucial in ensuring compliance and efficiency in processing US export transactions and providing backup support for North America Freight Bill Payment & Auditing.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Process export transactions via SAP for shipments out of Contract Manufacturing Organization partners within the mainland US and Puerto Rico
Ensure compliance with all US regulations and internal trade standards for trade compliance
Field export requests from External Manufacturing operations personnel, transact exports in our company’s instance of SAP, and troubleshoot routine and exceptional transaction issues
Provide backup support for North America Freight Bill Payment & Auditing (FBP&A) SME, including raising and maintaining transportation POs, performing monthly accruals, engaging with budget holders, and liaising with our external freight payment & auditing vendor
Provide foundational coverage for US Export Customer Service personnel to maintain continuity of communication and limited transactional support
Qualification
Required
Extensive SAP operations knowledge
Strong organizational skills
Trade compliance experience
Prior experience with freight payment and auditing
Minimum of 3-5 years of import, export, domestic transportation, or freight bill payment experience
Preferred
Experience with all modes of international and domestic transportation for freight bill payment and auditing
Familiarity with ECC and GTS modules of SAP
Experience in export order management
Bachelor's Degree in Supply Chain or related field
Benefits
Medical
Dental
Vision healthcare and other insurance benefits (for employee and family)
Retirement benefits, including 401(k)
Paid holidays
Vacation
Compassionate and sick days
Company
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Funding
Current Stage
Public CompanyTotal Funding
$5.59MKey Investors
Private Capital AdvisorsGavi, the Vaccine Alliance
2018-11-25Post Ipo Equity· $0.59M
2016-01-21Series Unknown· $5M
1980-12-19IPO
Leadership Team
Recent News
Company data provided by crunchbase